Posterior Reversible Encephalopathy Syndrome after Hematopoietic Cell Transplantation in Children with Hemoglobinopathies Javid Gaziev, Simone Marziali, Katia Paciaroni, Antonella Isgrò, Francesca Di Giuliano, Giorgia Rossi, Marco Marziali, Gioia De Angelis, Cecilia Alfieri, Michela Ribersani, Marco Andreani, Maria Giuseppina Palmieri, Fabio Placidi, Andrea Romigi, Francesca Izzi, Roberto Floris, Nicola Biagio Mercuri Biology of Blood and Marrow Transplantation Volume 23, Issue 9, Pages 1531-1540 (September 2017) DOI: 10.1016/j.bbmt.2017.05.033 Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 (A) Cumulative incidence of PRES in patients with thalassemia or SCD. (B) Cumulative incidence of PRES in patients with or without hypertension. (C) Cumulative incidence of PRES in patients with grades II to IV or grades 0 to I acute GVHD. Biology of Blood and Marrow Transplantation 2017 23, 1531-1540DOI: (10.1016/j.bbmt.2017.05.033) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 (A) Kaplan-Meier estimates of the probability of OS of the entire cohort of patients. (B) Kaplan-Meier estimates of the probability of OS of patients with thalassemia who received HLA-identical sibling transplantation. (C) Kaplan-Meier estimates of the probability of DFS of patients with thalassemia who received HLA-identical sibling transplantation. (D) Kaplan-Meier estimates of the probability of OS and DFS of patients with SCD who received HLA-identical sibling transplantation. Biology of Blood and Marrow Transplantation 2017 23, 1531-1540DOI: (10.1016/j.bbmt.2017.05.033) Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions